+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Viracta Therapeutics

VIRXNASDAQ

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.577300

0.035.44%

Pre-Market: Jul 17, 7:56 AM EDT

15 minutes delayed

Viracta Therapeutics (VIRX) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Viracta Therapeutics (NASDAQ:VIRX) Stock

Viracta Therapeutics Stock (NASDAQ: VIRX)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, June 18, 2024

Viracta Therapeutics Granted US Patent #12012...
Benzinga Newsdesk

Tuesday, June 11, 2024

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Thursday, May 23, 2024

Oppenheimer Maintains Outperform on Viracta T...
Benzinga Newsdesk

Tuesday, May 14, 2024

Viracta Therapeutics Appoints Michael Faerm A...
Benzinga Newsdesk

Thursday, May 09, 2024

Viracta Therapeutics Q1 2024 Adj EPS $(0.23) ...
Benzinga Newsdesk

Wednesday, April 24, 2024

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights

Wednesday, April 17, 2024

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Oppenheimer Maintains Outperform on Viracta T...
Benzinga Newsdesk

Tuesday, April 16, 2024

HC Wainwright & Co. Reiterates Buy on Viracta...
Benzinga Newsdesk

Monday, April 15, 2024

Why Is Small-Cap Cancer Drug Developer Viracta Therapeutics Stock Trading Lower On Monday?
Vandana Singh
Viracta Therapeutics shares are trading lower...
Benzinga Newsdesk
Viracta Therapeutics Announces Topline Nana-v...
Benzinga Newsdesk

Monday, April 01, 2024

Viracta Therapeutics To Present Topline Nana-...
Benzinga Newsdesk

Tuesday, March 12, 2024

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Viracta...
Benzinga Newsdesk

Friday, March 08, 2024

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Thursday, February 29, 2024

Viracta Therapeutics Completes Second-Stage E...
Benzinga Newsdesk

Friday, January 05, 2024

CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Viracta ...
Benzinga Newsdesk

Thursday, January 04, 2024

Viracta Therapeutics Provides Clinical Update...
Benzinga Newsdesk

Tuesday, December 12, 2023

Viracta Therapeutics Says FDA Granted Orphan ...
Benzinga Newsdesk

Monday, December 04, 2023

Viracta Therapeutics Announces Interim Data F...
Benzinga Newsdesk

Friday, November 10, 2023

RBC Capital Maintains Outperform on Viracta T...
Benzinga Newsdesk

Thursday, November 09, 2023

Viracta Therapeutics shares are trading lower...
Benzinga Newsdesk
Viracta Therapeutics: Q3 Earnings Insights
Benzinga Insights
Viracta Therapeutics Q3 EPS $(0.33) Misses $(...
Benzinga Newsdesk

Wednesday, November 08, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights

Thursday, October 05, 2023

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
RBC Capital Reiterates Outperform on Viracta ...
Benzinga Newsdesk

Tuesday, August 15, 2023

Expert Ratings for Viracta Therapeutics
Benzinga Insights
RBC Capital Reiterates Outperform on Viracta ...
Benzinga Newsdesk
SVB Securities Maintains Outperform on Viract...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Viracta...
Benzinga Newsdesk

Monday, August 14, 2023

Viracta Therapeutics Q2 EPS $(0.32) Misses $(0.28) Estimate
Happy Mohamed

Tuesday, August 08, 2023

Viracta Therapeutics Announces Publication In Blood Advances Demonstrating Promising And Durable Signal Of Nana-val Efficacy In Patients With Relapsed Or Refractory Epstein-Barr Virus-Positive Lymphoma
Happy Mohamed

Monday, July 31, 2023

Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Benzinga Insights
EF Hutton Initiates Coverage On Viracta Thera...
Benzinga Newsdesk

Wednesday, June 28, 2023

Viracta Therapeutics Says Pivotal Cancer Trial Achieves Efficacy Threshold For Expansion Into Next Stage
Vandana Singh
Viracta Therapeutics' NAVAL-1 Trial Achieves ...
Benzinga Newsdesk

Wednesday, May 17, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Viracta Therapeutics To Present At RBC Capita...
Happy Mohamed

Wednesday, May 10, 2023

Analyst Ratings for Viracta Therapeutics
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Viracta ...
Benzinga Newsdesk

Tuesday, May 09, 2023

RBC Capital Maintains Outperform on Viracta T...
Benzinga Newsdesk

Friday, May 05, 2023

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights

Wednesday, April 26, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved